Online Course
07
Oct
2022
2022
08
Oct
2022
2022
Breast Cancer in Young Women Sixth International Consensus Symposium - Online
Chairs
Olivia Pagani, CH - Shani Paluch-Shimon, IL
Date
7-8 October 2022
Background
Olivia Pagani, CH - Shani Paluch-Shimon, IL
Date
7-8 October 2022
Background
Breast cancer in young women is a complex disease, occurring when women are at the peak of their reproductive years, family life and careers. Being a somewhat rare disease, the optimal management of these patients is based on scientific data derived from clinical trials mostly conducted on older women.
Many aspects of breast cancer in young women are therefore poorly understood (e.g., aetiology and biology among others) and research is much needed in this field. In addition, young women have many years ahead of them to suffer the long-term effects of treatment and specific survivorship issues (fertility and job, among others).
The Breast Cancer in Young Women Sixth International Consensus Symposium 2022 will address challenges and opportunities in different cultural and economic settings, follow-up care, diagnostic and treatment guidelines, from early to advanced breast cancer and survivorship, updating the available evidence and generating future research concepts and collaborations with an interactive, international, and collaborative spirit. It will also include a vote (not accessible to the public) on specific statements and a Panel Consensus Controversy Highlights that will form the basis for a Consensus Guidelines Manuscript to be published after the Symposium.
Learning Objectives
- In-depth learning and update of the scientific and clinical aspects of breast cancer in young women
- Highlighting of the importance of multi-disciplinary management
- Focus on clinical research priorities and future perspectives, involving patients’ advocates in setting the agenda
- Participation in the discussion of consensus guidelines
Target Group
Medical Oncologists – Surgeons – Gynaecologists – Radiation Oncologists – Breast Radiologists – Pathologists – Onco-geneticists – Nurses – Patient Advocates – Psycho-oncologists.
Format
The Symposium will be held online with the participation of world-renowned Experts.
The event will be accessible to the audience by registering on the SPCC e-learning platform OncoCorner. Material will remain available on-demand on the OncoCorner website.
Content
The event will consist of:
1. ON-DEMAND MATERIAL
2. CONSECUTIVE 2-DAY LIVE SESSIONS
RECORDED PRESENTATIONS are available via the following links:
2. CONSECUTIVE 2-DAY LIVE SESSIONS
RECORDED PRESENTATIONS are available via the following links:
SESSION 1: Challenges in the management of young women with germline predisposition
1) The ethical implications of increasing genetic testing and new paradigms in counseling – L. Battistuzzi, IT
2) Fertility preservation and pregnancy in mutation carriers – M. Lambertini, IT
3) Germline Genetic Testing for Breast Cancer: where are we heading? – C. Turnbull, UK
SESSION 2: Does financial toxicity impact patient care?
4) The surgical perspective - M.J. Cardoso, PT
5) The medical oncology perspective (focus on ABC) – A. Eniu, CH
6) The patient perspective – V. Sulosaari, FI
SESSION 3: New directions
7) Immune checkpoint inhibitors: for whom and when – G. Curigliano, IT
8) The role of PARP inhibitors in early and advanced disease – S. Paluch-Simon, IL
SESSION 4: What should we change in BCY6 guidelines?
9) Molecular testing in hormone positive early breast cancer – F. Cardoso, PT
10) Preoperative systemic treatment – K. Gelmon, CA
11) Target Therapies in Advanced Breast Cancer (ABC) – R. A. Dent, SG
12) Endocrine therapy – O. Pagani, CH
13) Escalation & de-escalation: progress made, challenges that remain – N. Harbeck, DE
SESSION 5: Follow-up care: focus on return to work
14) The Asian perspective – Q. Liu, CN
15) Return to work: The North American perspective – S. M. Rosenberg, US
16) Employment trajectories of young women with breast cancer: An ongoing prospective cohort study in Italy and Switzerland – M. Ruggeri, CH
SESSION 6: Pregnancy and breast cancer
17) Breast cancer during and after pregnancy: any difference? – F. Amant, BE
18) Pregnancy after breast cancer – F. A. Peccatori, IT
SESSION 7: Local therapy and quality-of-life outcomes in young women
19) The psycho-oncologist viewpoint – M. Braun, IL
20) The surgical viewpoint – O. D. Gentilini, IT
Continuing Medical Education accreditation
Request for Continuing Medical Education accreditation was submitted to ACOE.
The programme was recognised as being of high quality from both a scientific and didactic point of view and was awarded 6 CME credits.
Request for Continuing Medical Education accreditation was submitted to ACOE.
The programme was recognised as being of high quality from both a scientific and didactic point of view and was awarded 6 CME credits.
Acknowledgements
Sharing Progress in Cancer Care wishes to express its appreciation to AstraZeneca, Debiopharm, Eli Lilly and Company and Pfizer Inc. for their independent support via educational grants.
Disclosure of Auspices
EUSOMA: "Any recommendations, resolutions or other formal outcome(s) of this EUSOMA auspiced event does not necessarily reflect EUSOMA’s agreement or endorsement of any such outcomes".
07/10/2022 14:00 CEST
DAY 1
07/10/2022 14:00 CEST
Welcome and introduction
Chair: Pagani Olivia, CH
Chair: Paluch-Shimon Shani, IL
07/10/2022 14:10 CEST
Web-based Education and Supportive Care Intervention for Navigating AYAs through the Cancer Care Continuum
Expert: Partridge Ann H. , US
07/10/2022 14:30 CEST
Controversial key points on challenges in the management of young women with germline predisposition
Expert: Battistuzzi Linda , IT
Expert: Lambertini Matteo, IT
Expert: Turnbull Clare, UK
07/10/2022 14:35 CEST
Live Q&A and discussion
Expert: Battistuzzi Linda , IT
Expert: Lambertini Matteo, IT
Expert: Turnbull Clare, UK
Moderator: Pruneri Giancarlo, IT
07/10/2022 14:50 CEST
Controversial key points on the impact of financial toxicity on patient care
Expert: Cardoso Maria-João, PT
Expert: Eniu Alexandru, CH
Expert: Sulosaari Virpi, FI
07/10/2022 14:55 CEST
Live Q&A and discussion
Expert: Cardoso Maria-João, PT
Expert: Eniu Alexandru, CH
Expert: Sulosaari Virpi, FI
Moderator: Senkus Elzbieta, PL
07/10/2022 15:10 CEST
Controversial key points on new directions
Expert: Curigliano Giuseppe, IT
Expert: Paluch-Shimon Shani, IL
07/10/2022 15:15 CEST
Live Q&A and discussion
Expert: Curigliano Giuseppe, IT
Expert: Paluch-Shimon Shani, IL
Moderator: Liu Hong, CN
07/10/2022 15:30 CEST
Controversial key points on what should be changed in BCY6 guidelines
Expert: Cardoso Fatima, PT
Expert: Dent Rebecca A. , SG
Expert: Gelmon Karen , CA
Expert: Harbeck Nadia, DE
Expert: Pagani Olivia, CH
07/10/2022 15:40 CEST
Live Q&A and discussion
Expert: Cardoso Fatima, PT
Expert: Dent Rebecca A. , SG
Expert: Gelmon Karen , CA
Expert: Pagani Olivia, CH
Moderator: Partridge Ann H. , US
07/10/2022 16:00 CEST
Controversial key points on the follow-up care: focus on return to work
Expert: Liu Qiang , CN
Expert: Rosenberg Shoshana M. , US
Expert: Ruggeri Monica, CH
07/10/2022 16:05 CEST
Live Q&A and discussion
Expert: Liu Qiang , CN
Expert: Rosenberg Shoshana M. , US
Expert: Ruggeri Monica, CH
Moderator: Pagani Olivia, CH
07/10/2022 16:20 CEST
Controversial key points on pregnancy and breast cancer
Expert: Amant Frédéric , BE
Expert: Peccatori Fedro, IT
07/10/2022 16:25 CEST
Live Q&A and discussion
Expert: Amant Frédéric , BE
Expert: Lambertini Matteo, IT
Moderator: Azim Jr. Hatem A., EG
07/10/2022 16:40 CEST
Controversial key points on local therapy and quality-of-life outcomes in young women
Expert: Braun Michal , IL
Expert: Gentilini Oreste D. , IT
Expert: Poortmans Philip, BE
07/10/2022 16:45 CEST
Live Q&A and discussion
Expert: Braun Michal , IL
Expert: Poortmans Philip, BE
Moderator: Gentilini Oreste D. , IT
07/10/2022 17:00 CEST
Young Survival Coalition Project 528: The first-ever global needs assessment of young adults affected by breast cancer
Expert: Ajango Mary Farrell, US
07/10/2022 17:15 CEST
Closing Remarks
Chair: Pagani Olivia, CH
Chair: Paluch-Shimon Shani, IL
08/10/2022 14:00 CEST
DAY 2
08/10/2022 14:00 CEST
Welcome and introduction
Chair: Pagani Olivia, CH
Chair: Paluch-Shimon Shani, IL
08/10/2022 14:10 CEST
Patient advocate perspective: EUROPA DONNA
Expert: Spanic Tanja, SI
08/10/2022 14:20 CEST
Patient advocate perspective: YOUNG SURVIVAL COALITION
Expert: Merschdorf Jennifer , US
08/10/2022 14:40 CEST
Q&A and Live Discussion
Expert: Spanic Tanja, SI
08/10/2022 14:50 CEST
Panel Consensus Controversy Highlights
Chair: Pagani Olivia, CH
Chair: Paluch-Shimon Shani, IL
Expert: Azim Jr. Hatem A., EG
Expert: Cardoso Maria-João, PT
Expert: Curigliano Giuseppe, IT
Expert: Dent Rebecca A. , SG
Expert: Gelmon Karen , CA
Expert: Gentilini Oreste D. , IT
Expert: Lambertini Matteo, IT
Expert: Liu Hong, CN
Expert: Liu Qiang , CN
Expert: Merschdorf Jennifer , US
Expert: Partridge Ann H. , US
Expert: Poortmans Philip, BE
Expert: Pruneri Giancarlo, IT
Expert: Senkus Elzbieta, PL
Expert: Spanic Tanja, SI
Expert: Sulosaari Virpi, FI
08/10/2022 16:50 CEST
Closing Remarks
Chair: Pagani Olivia, CH
Chair: Paluch-Shimon Shani, IL
Ajango Mary Farrell
Young Survival Coalition, New York, USA
Amant Frédéric
University Hospitals of Leuven, Leuven, Belgium
Azim Jr. Hatem A.
Cairo Oncology Center, Cairo, Egypt
Battistuzzi Linda
University of Genoa, Genoa, Italy
Braun Michal
The Academic College of Tel Aviv Yaffo and Hadassah University Hospital, Jerusalem, Israel
Cardoso Fatima
Breast Unit, Champalimaud Clinical Center and ABC Global Alliance, Lisbon, Portugal
Cardoso Maria-João
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal
Curigliano Giuseppe
University of Milan and Istituto Europeo di Oncologia, Milan, Italy
Dent Rebecca A.
National Cancer Center Singapore, Singapore, Singapore
Eniu Alexandru
Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais, Rennaz, Switzerland
Gelmon Karen
BC Cancer Agency, Department of Medical Oncology, Vancouver, Canada
Gentilini Oreste D.
Vita-Salute San Raffaele University and San Raffaele Scientific Institute, Milan, Italy
Harbeck Nadia
Breast Center, LMU University Hospital, Munich, Germany
Lambertini Matteo
IRCCS Policlinico San Martino Hospital and University of Genoa, Genoa, Italy
Liu Hong
Tianjin Medical University Cancer Institute & Hospital (TJMUCH), Chinese Anti-Cancer Association (CACA), Tianjin, China
Liu Qiang
Sun Yat-sen Memorial Hospital, Guangzhou, China
Merschdorf Jennifer
Young Survival Coalition, New York, USA
Pagani Olivia
Geneva University Hospitals and Lugano University, Lugano, Switzerland
Paluch-Shimon Shani
Hadassah University Hospital - Sharett Institute of Oncology, Jerusalem, Israel
Partridge Ann H.
Harvard Medical School and Dana-Farber Cancer Institute, Boston, USA
Peccatori Fedro
Istituto Europeo di Oncologia IRCCS, Milan, Italy
Poortmans Philip
GZA Ziekenhuizen Campus Sint-Augustinus and Antwerp University, Antwerp, Belgium
Pruneri Giancarlo
IRCCS National Cancer Institute, Milan, Italy
Rosenberg Shoshana M.
Weill Cornell Medicine, New York, USA
Ruggeri Monica
International Breast Cancer Study Group, Program for Young Patients, Bern, Switzerland
Senkus Elzbieta
Medical University of Gdansk, Gdansk, Poland
Spanic Tanja
Europa Donna, The European Breast Cancer and Europa Donna Slovenia, Ljubljana, Slovenia
Sulosaari Virpi
European Oncology Nursing Society (EONS) and Turku University of Applied Sciences, Turku, Finland
Turnbull Clare
The Institute of Oncology Research and Royal Marsden NHS Foundation Trust, London, United Kingdom
BREAST CANCER
PATIENT ADVOCACY
QUALITY OF LIFE